Published in BMJ on November 07, 1992
Quality of life measures in health care. III: Resource allocation. BMJ (1992) 2.31
Quality of Life Analysis of a Radiation Dose-Escalation Study of Patients With Non-Small-Cell Lung Cancer: A Secondary Analysis of the Radiation Therapy Oncology Group 0617 Randomized Clinical Trial. JAMA Oncol (2016) 2.19
Quality of life in patients with osteoporosis. Osteoporos Int (2004) 2.14
Validation of a specific quality of life questionnaire for functional digestive disorders. Gut (1999) 1.93
Intestinal microbiota in healthy adults: temporal analysis reveals individual and common core and relation to intestinal symptoms. PLoS One (2011) 1.88
Putting trials on trial--the costs and consequences of small trials in depression: a systematic review of methodology. J Epidemiol Community Health (1997) 1.83
Comparison of measures to assess outcomes in total hip replacement surgery. Qual Health Care (1996) 1.60
How do common chronic conditions affect health-related quality of life? Br J Gen Pract (2009) 1.59
Negative impact of chronic obstructive pulmonary disease on the health-related quality of life of patients. Results of the EPIDEPOC study. Health Qual Life Outcomes (2006) 1.49
Quality of life as outcome in the treatment of osteoporosis: the development of a questionnaire for quality of life by the European Foundation for Osteoporosis. Osteoporos Int (1997) 1.43
Quality of life assessment in children: a review of conceptual and methodological issues in multidimensional health status measures. J Epidemiol Community Health (1996) 1.35
Impact of incident vertebral fractures on health related quality of life (HRQOL) in postmenopausal women with prevalent vertebral fractures. Osteoporos Int (2004) 1.31
Prospective study of health related quality of life before and after coronary artery bypass grafting: outcome at five years. Heart (1999) 1.25
The problem with health measurement. Patient Prefer Adherence (2011) 1.10
Fracture incidence and changes in quality of life in women with an inadequate clinical outcome from osteoporosis therapy: the Observational Study of Severe Osteoporosis (OSSO). Osteoporos Int (2007) 1.03
Inconsistencies in quality of life data collection in clinical trials: a potential source of bias? Interviews with research nurses and trialists. PLoS One (2013) 1.01
Patient reported outcomes (PROs) in clinical trials: is 'in-trial' guidance lacking? a systematic review. PLoS One (2013) 1.00
Stopping rules, interim analyses and data monitoring committees. Br J Cancer (1993) 0.99
Comparison of the discriminative ability of a generic and a condition-specific OHRQoL measure in adolescents with and without normative need for orthodontic treatment. Health Qual Life Outcomes (2008) 0.98
Validation of the Fibromyalgia Survey Questionnaire within a cross-sectional survey. PLoS One (2012) 0.98
Quality of life assessment in clinical cancer research. Br J Cancer (1994) 0.97
Health-related quality of life following blind rehabilitation. Qual Life Res (2008) 0.97
A comparison of the Nottingham Health Profile and Short Form 36 Health Survey in patients with chronic lower limb ischaemia in a longitudinal perspective. Health Qual Life Outcomes (2004) 0.95
Functional outcome in patients after excision of extracanalicular acoustic neuromas using the suboccipital approach. Ann R Coll Surg Engl (1995) 0.94
Quality of life in cardiovascular disease. Br Heart J (1993) 0.92
Validation of an asthma symptom diary for interventional studies. Arch Dis Child (1999) 0.91
Patient-identified disease burden in facioscapulohumeral muscular dystrophy. Muscle Nerve (2012) 0.90
Quality of life measurements in patients with osteoporosis and fractures. Clinics (Sao Paulo) (2012) 0.85
Quality-of-life measurements in the evaluation of treatment: proposed guidelines. Br J Clin Pharmacol (1995) 0.85
Validation of the Patient-Doctor-Relationship Questionnaire (PDRQ-9) in a representative cross-sectional German population survey. PLoS One (2014) 0.85
Impact of cancer occurrence on health-related quality of life: a longitudinal pre-post assessment. Health Qual Life Outcomes (2004) 0.85
Performance of the Dutch SF-36 version 2 as a measure of health-related quality of life in patients with rheumatoid arthritis. Health Qual Life Outcomes (2013) 0.83
["Fragebogen zum Kindlichen Sehvermögen (FKS)". Assessment of quality of life with the German version of the Children's Visual Function Questionnaire]. Ophthalmologe (2009) 0.81
Initial prognostic factors in small-cell lung cancer patients predicting quality of life during chemotherapy. Swiss Group for Clinical Cancer Research (SAKK). Br J Cancer (1996) 0.81
Psychometric validation of the EuroQoL 5-Dimension 5-Level (EQ-5D-5L) in Chinese patients with adolescent idiopathic scoliosis. Scoliosis Spinal Disord (2016) 0.80
A patient-reported outcome instrument to assess the impact of oropharyngeal mucositis on health-related quality of life: a longitudinal psychometric evaluation. Support Care Cancer (2008) 0.78
Assessing health-related quality of life in COPD: comparing generic and disease-specific instruments with focus on comorbidities. BMC Pulm Med (2016) 0.76
Do patient-reported outcomes have a role in the management of patients with cystic fibrosis? Front Pharmacol (2012) 0.75
Validation of the Turkish version of the Celiac Disease Questionnaire (CDQ). Health Qual Life Outcomes (2015) 0.75
Systematic collection of patient reported outcome research data: A checklist for clinical research professionals. Contemp Clin Trials (2016) 0.75
Quality of life in patients with chronic thromboembolic pulmonary hypertension. Eur Respir J (2016) 0.75
Effect size. BMJ (1995) 0.75
Quality of life in atrial fibrillation. J Interv Card Electrophysiol (2000) 0.75
The MOS short-form general health survey. Reliability and validity in a patient population. Med Care (1988) 21.00
The Sickness Impact Profile: development and final revision of a health status measure. Med Care (1981) 18.20
Effect sizes for interpreting changes in health status. Med Care (1989) 15.39
Measuring change over time: assessing the usefulness of evaluative instruments. J Chronic Dis (1987) 9.25
The effects of antihypertensive therapy on the quality of life. N Engl J Med (1986) 5.32
Reproducibility and responsiveness of health status measures. Statistics and strategies for evaluation. Control Clin Trials (1991) 4.87
Quality of life measures in health care. I: Applications and issues in assessment. BMJ (1992) 4.53
The arthritis impact measurement scales. Further investigations of a health status measure. Arthritis Rheum (1982) 1.97
A self-rating scale of distress. Psychol Med (1973) 1.94
The Bradford Somatic Inventory. A multi-ethnic inventory of somatic symptoms reported by anxious and depressed patients in Britain and the Indo-Pakistan subcontinent. Br J Psychiatry (1991) 1.72
The measurement of quality of life in hypertensive patients: a practical approach. Br J Clin Pharmacol (1990) 1.15
Review: audit measures: quality of life instruments for everyday use with elderly patients. Age Ageing (1992) 1.14
Framework for design and evaluation of complex interventions to improve health. BMJ (2000) 28.39
CONTROL OF GRAM-NEGATIVE BACTERIA IN EXPERIMENTAL ANIMALS BY STREPTOMYCIN. Science (1944) 11.30
Evaluating clinical accuracy of systems for self-monitoring of blood glucose. Diabetes Care (1988) 9.27
Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts. N Engl J Med (2011) 7.89
Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice. Proc Natl Acad Sci U S A (1998) 7.69
Questionnaire on the perceptions of patients about total hip replacement. J Bone Joint Surg Br (1996) 7.44
Questionnaire on the perceptions of patients about total knee replacement. J Bone Joint Surg Br (1998) 7.20
Distribution of isoprenoid quinone structural types in bacteria and their taxonomic implication. Microbiol Rev (1981) 6.91
Report of an international working group to standardize response criteria for myelodysplastic syndromes. Blood (2000) 6.27
Human infection with Ehrlichia canis, a leukocytic rickettsia. N Engl J Med (1987) 6.06
POSSUM: a scoring system for surgical audit. Br J Surg (1991) 6.05
Routine follow up of breast cancer in primary care: randomised trial. BMJ (1996) 5.91
Wall stress and patterns of hypertrophy in the human left ventricle. J Clin Invest (1975) 5.72
CAFASP-1: critical assessment of fully automated structure prediction methods. Proteins (1999) 5.54
Mode of proviral activation of a putative mammary oncogene (int-1) on mouse chromosome 15. Nature (1984) 5.53
An integrated nanoliter DNA analysis device. Science (1998) 5.40
The development and validation of a short measure of functioning and well being for individuals with Parkinson's disease. Qual Life Res (1995) 5.36
Comparison of UK paediatric cardiac surgical performance by analysis of routinely collected data 1984-96: was Bristol an outlier? Lancet (2001) 5.26
Differentiation and reversal of malignant changes in colon cancer through PPARgamma. Nat Med (1998) 5.16
Breaking down language barriers. The NHS needs to provide accessible interpreting services for all. BMJ (1998) 5.09
Prevention of diarrhea and pneumonia by zinc supplementation in children in developing countries: pooled analysis of randomized controlled trials. Zinc Investigators' Collaborative Group. J Pediatr (1999) 4.57
Quality of life measures in health care. I: Applications and issues in assessment. BMJ (1992) 4.53
Analysis of a cluster of surgical failures. Application to a series of neonatal arterial switch operations. J Thorac Cardiovasc Surg (1994) 4.28
The chemokine receptor CXCR4 is required for the retention of B lineage and granulocytic precursors within the bone marrow microenvironment. Immunity (1999) 4.24
Problems in the conceptual framework of patient satisfaction research: an empirical exploration. Sociol Health Illn (1983) 4.04
A SEARCH FOR VIRUS-INACTIVATING SUBSTANCES AMONG MICROORGANISMS. Science (1945) 3.86
Patients' health related quality of life before and after aesthetic surgery. Br J Plast Surg (1996) 3.81
The use of the Oxford hip and knee scores. J Bone Joint Surg Br (2007) 3.77
Measuring the impact of MS on walking ability: the 12-Item MS Walking Scale (MSWS-12). Neurology (2003) 3.75
Questionnaire on the perceptions of patients about shoulder surgery. J Bone Joint Surg Br (1996) 3.72
The Parkinson's Disease Questionnaire (PDQ-39): development and validation of a Parkinson's disease summary index score. Age Ageing (1997) 3.71
Referrals to neurologists for headaches not due to structural disease. J Neurol Neurosurg Psychiatry (1981) 3.69
Cueing training in the home improves gait-related mobility in Parkinson's disease: the RESCUE trial. J Neurol Neurosurg Psychiatry (2007) 3.60
The Multiple Sclerosis Impact Scale (MSIS-29): a new patient-based outcome measure. Brain (2001) 3.51
Genome-wide survey of protein kinases required for cell cycle progression. Nature (2004) 3.40
Randomised controlled trial of laparoscopic versus open mesh repair for inguinal hernia: outcome and cost. BMJ (1998) 3.26
Evaluating medical expert systems: what to test and how? Med Inform (Lond) (1990) 3.24
Epidemiology of hip and knee pain and its impact on overall health status in older adults. Rheumatology (Oxford) (2004) 3.22
Statistical shape analysis of neuroanatomical structures based on medial models. Med Image Anal (2003) 3.17
A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial. J Clin Endocrinol Metab (2001) 3.16
The glucan components of the cell wall of baker's yeast (Saccharomyces cerevisiae) considered in relation to its ultrastructure. Biochem J (1969) 3.02
Temporal and spatial expression patterns of the small heat shock (hsp16) genes in transgenic Caenorhabditis elegans. Mol Biol Cell (1992) 2.98
Self-reported functioning and well-being in patients with Parkinson's disease: comparison of the short-form health survey (SF-36) and the Parkinson's Disease Questionnaire (PDQ-39) Age Ageing (1995) 2.92
PDQ-39: a review of the development, validation and application of a Parkinson's disease quality of life questionnaire and its associated measures. J Neurol (1998) 2.85
The Nottingham Health Profile: an analysis of its sensitivity in differentiating illness groups. Soc Sci Med (1988) 2.83
Including qualitative research in systematic reviews: opportunities and problems. J Eval Clin Pract (2001) 2.81
Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of U.S. adults. Epidemiology (1993) 2.79
Predicting difficult intubation. Br J Anaesth (1988) 2.78
Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjögren's syndrome keratoconjunctivitis sicca. Curr Eye Res (1999) 2.75
Qualitative research in health care: II. A structured review and evaluation of studies. J Eval Clin Pract (1996) 2.68
Solid-phase synthesis of peptide nucleic acids. J Pept Sci (1997) 2.67
Frequency and clinical significance of BCR-ABL mutations in patients with chronic myeloid leukemia treated with imatinib mesylate. Leukemia (2006) 2.66
Qualitative research in systematic reviews. Has established a place for itself. BMJ (2001) 2.64
Cessation of gonadotropin-releasing hormone agonist therapy combined with high-dose gonadotropin stimulation yields favorable pregnancy results in low responders. Fertil Steril (1998) 2.57
Specialist and general practice views on routine follow-up of breast cancer patients in general practice. Fam Pract (1995) 2.56
Neonatal detection of developmental dysplasia of the hip (DDH) J Bone Joint Surg Br (1998) 2.56
Aspirin, paracetamol, and haematemesis and melaena. Gut (1982) 2.55
DNA sequences of two yeast promoter-up mutants. Nature (1983) 2.50
Normal flow (TIMI-3) before mechanical reperfusion therapy is an independent determinant of survival in acute myocardial infarction: analysis from the primary angioplasty in myocardial infarction trials. Circulation (2001) 2.43
Emergence of gentamicin- and methicillin-resistant Staphylococcus aureus strains in New York City hospitals. J Clin Microbiol (1981) 2.39
The experience of losing a job: reported changes in health, symptoms and illness behavior. Psychosom Med (1975) 2.37
Quality of life measures in health care. III: Resource allocation. BMJ (1992) 2.31
The TAPS project. 6: New long-stay psychiatric patients and social deprivation. Br J Psychiatry (1992) 2.29
Quality of life in older people: a structured review of generic self-assessed health instruments. Qual Life Res (2005) 2.26
Comparison of breast cancer patient satisfaction with follow-up in primary care versus specialist care: results from a randomized controlled trial. Br J Gen Pract (1999) 2.24
The prevalence of amyloid (A4) protein deposits within the cerebral and cerebellar cortex in Down's syndrome and Alzheimer's disease. Acta Neuropathol (1990) 2.23
Differential expression of TGF beta 1, beta 2 and beta 3 genes during mouse embryogenesis. Development (1991) 2.21
Predicting the one-year course of adolescent major depression. J Am Acad Child Adolesc Psychiatry (1995) 2.20
Genetic transfer and bacterial taxonomy. Bacteriol Rev (1970) 2.10
Patients with cancer holding their own records: a randomised controlled trial. Br J Gen Pract (2000) 2.09
Characterization of transposable element-associated mutations that alter yeast alcohol dehydrogenase II expression. Mol Cell Biol (1983) 2.09
Use of rifabutin with protease inhibitors for human immunodeficiency virus-infected patients with tuberculosis. Clin Infect Dis (2000) 2.08
Prevalence and incidence of adults consulting for shoulder conditions in UK primary care; patterns of diagnosis and referral. Rheumatology (Oxford) (2005) 2.07
High-avidity human IgG kappa monoclonal antibodies from a novel strain of minilocus transgenic mice. Nat Biotechnol (1996) 2.07
Orthostatic hypotension as a risk factor for stroke: the atherosclerosis risk in communities (ARIC) study, 1987-1996. Stroke (2000) 2.05
Self-report quality of life measure for people with schizophrenia: the SQLS. Br J Psychiatry (2000) 2.05
Prevalence of visual impairment in people aged 75 years and older in Britain: results from the MRC trial of assessment and management of older people in the community. Br J Ophthalmol (2002) 2.03
Overestimation of copper deficiency in horses? Vet Rec (1995) 2.03
A retinoblastoma-binding protein related to a negative regulator of Ras in yeast. Nature (1993) 2.03
Rats of the genus Rattus are reservoir hosts for pathogenic Bartonella species: an Old World origin for a New World disease? J Infect Dis (1999) 2.03
Nova Scotia only province to provide clinic for "environmentally sensitive" patients. CMAJ (1992) 2.01
Telling patients there is nothing wrong. BMJ (1996) 2.01
Comparing health inequality in men and women: prospective study of mortality 1986-96. BMJ (2000) 2.00
An investigation of risk factors for symptomatic osteoarthritis of the knee in women using a life course approach. J Epidemiol Community Health (2003) 1.99
Clinical and electrophysiological differences between patients with arrhythmogenic right ventricular dysplasia and right ventricular outflow tract tachycardia. Eur Heart J (2003) 1.99
Effects of polychlorinated biphenyls on the nervous system. Toxicol Ind Health (2000) 1.97
Molecular analysis of the NF2 tumor-suppressor gene in schwannomatosis. Am J Hum Genet (1997) 1.96
Reclassification of 'Corynebacterium haemolyticum' (MacLean, Liebow & Rosenberg) in the genus Arcanobacterium gen.nov. as Arcanobacterium haemolyticum nom.rev., comb.nov. J Gen Microbiol (1982) 1.96
Long-distance charge transport in duplex DNA: the phonon-assisted polaron-like hopping mechanism. Proc Natl Acad Sci U S A (1999) 1.95
Issues and themes in computer aided design for external prosthetics and orthotics. J Biomed Eng (1988) 1.94
Pregnancy in cyanotic congenital heart disease. Outcome of mother and fetus. Circulation (1994) 1.93
Sick hospital, sick doctor: Halifax hospital tries to cope with "environmental illness". CMAJ (1992) 1.93
The development and validation of a patient-reported questionnaire to assess outcomes of elbow surgery. J Bone Joint Surg Br (2008) 1.93
Association between human tumor colony-forming assay results and response of an individual patient's tumor to chemotherapy. Am J Med (1981) 1.92